Compare ACHV & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACHV | PFLT |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 833.5M | 742.1M |
| IPO Year | 2018 | 2010 |
| Metric | ACHV | PFLT |
|---|---|---|
| Price | $8.48 | $7.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $14.67 | $10.50 |
| AVG Volume (30 Days) | ★ 1.3M | 878.5K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 14.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.16 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $6.83 |
| 52 Week High | $8.61 | $10.29 |
| Indicator | ACHV | PFLT |
|---|---|---|
| Relative Strength Index (RSI) | 69.38 | 53.55 |
| Support Level | $3.99 | $7.03 |
| Resistance Level | $8.61 | $7.67 |
| Average True Range (ATR) | 0.40 | 0.12 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 90.41 | 70.56 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate both current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generates revenue in the form of interest income on the debt securities and dividends.